Anticoagulation intensity and outcomes among patients prescribed oral anticoagulant therapy: a systematic review and meta-analysis.
about
Evidence-based management of anticoagulant therapy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice GuidelinesVitamin K antagonist use: evidence of the difficulty of achieving and maintaining target INR range and subsequent consequencesEffects on bleeding complications of pharmacogenetic testing for initial dosing of vitamin K antagonists: a systematic review and meta-analysisEffect of genetic variants, especially CYP2C9 and VKORC1, on the pharmacology of warfarinEffect of CYP2C9, VKORC1, and CYP4F2 polymorphisms on warfarin maintenance dose in children aged less than 18 years: a protocol for systematic review and meta-analysisShould patient characteristics influence target anticoagulation intensity for stroke prevention in nonvalvular atrial fibrillation?: the ATRIA study.A team-based approach to warfarin management in long term care: a feasibility study of the MEDeINR electronic decision support system.Differences in patient outcomes and chronic care management of oral anticoagulant therapy: an explorative studyImplications of using different methods to characterise anticoagulant control in patients with second generation mechanical heart valve prostheses.Thromboembolism.A Proposal for an Individualized Pharmacogenetic-Guided Warfarin Dosage Regimen for Puerto Rican Patients Commencing Anticoagulation Therapy.Point-of-Care International Normalized Ratio (INR) Monitoring Devices for Patients on Long-term Oral Anticoagulation Therapy: An Evidence-Based Analysis.Cost effectiveness of new oral anticoagulants for stroke prevention in patients with atrial fibrillation in two different European healthcare settingsMinor Oral Surgery Procedures in Patients Taking Warfarin: A 5-year retrospective study at Sultan Qaboos University Hospital, Sultanate of Oman.Dabigatran versus warfarin under standard or pharmacogenetic-guided management for the prevention of stroke and systemic thromboembolism in patients with atrial fibrillation: a cost/utility analysis using an analytic decision model.Low-intensity adjusted-dose warfarin for the prevention of hemodialysis catheter failure: a randomized, controlled trial.A systematic review on comparing 2 common models for management of warfarin therapy; pharmacist-led service versus usual medical care.Association Between Usual Vitamin K Intake and Anticoagulation in Patients Under Warfarin Therapy.Effects of computer-assisted oral anticoagulant therapy.Massachusetts Health Reform Cost Less and Was More Effective for Uninsured Individuals With Venous Thromboembolism: A Cost-Effectiveness Analysis.Effect of an interactive voice response system on oral anticoagulant managementUse of warfarin in people with low glomerular filtration rate or on dialysis.Menaquinones, bacteria, and the food supply: the relevance of dairy and fermented food products to vitamin K requirements.Effectiveness of pharmacist-participated warfarin therapy management: a systematic review and meta-analysis.Clinical outcomes of a collaborative, home-based postdischarge warfarin management service.Urgent reversal of vitamin K antagonist therapy.Treatment of warfarin-associated coagulopathy with vitamin K.Anticoagulation patient self-monitoring in the United States: considerations for clinical practice adoption.Genetics of ischemic stroke, stroke-related risk factors, stroke precursors and treatments.Vitamin K dosing to reverse warfarin based on INR, route of administration, and home warfarin dose in the acute/critical care setting.The future of inpatient anticoagulation management.A review of apixaban for stroke prevention in atrial fibrillation: insights from ARISTOTLE.Pharmacoepidemiological assessment of drug interactions with vitamin K antagonists.Commentary: Should Pharmacogenomic Evidence Be Considered in Clinical Decision Making? Focus on Select Cardiovascular Drugs.A Bayesian dose-individualization method for warfarin.Cost-effectiveness of pharmacogenetic-guided dosing of warfarin in the United Kingdom and Sweden.Development of a bayesian forecasting method for warfarin dose individualization.Two monitoring methods of oral anticoagulant therapy in patients with mechanical heart valve prothesis: a meta-analysis.Relevancy of positive trends in mortality and functional recovery after surgical treatment of acute subdural hematomas. Our 10-year experience.A higher international normalized ratio may be better for your patient
P2860
Q24632951-3FA50B40-98CE-48A3-9242-92965C314D02Q26746062-AC74A313-80CD-49A1-9D27-7A554FBF59BBQ27026134-E74C10C2-DE74-4318-859C-3C249723E9F0Q28276514-84DD4F81-E400-42B1-962E-0D83910CC087Q28276605-D4E43D9D-DBA4-4225-9EA8-2D21D9613574Q33572430-A8BFA196-08D5-4E4B-B11A-19B5ACDE274EQ33600407-AAEAD5EF-071E-46B1-ADFE-52E42DD2F31CQ33805364-F747F8DA-915B-4BB7-BC2E-ADE6B5AE1CD0Q33837185-E036C66C-682C-4D05-BC66-9B6413A46C64Q33840400-50860AD8-665F-4D70-BB3C-056985AFD01EQ34273608-F1E17763-640B-48DE-B0E1-7EABC5768B62Q34449234-F23ECE85-0D37-4882-81E5-58F55EBA8EC8Q34604533-42461C9D-C1C9-48CB-B9F5-3D49D1D3154FQ34782905-A1A7A919-BB9F-48B5-9D4F-3D299746D6C6Q34834319-237921C8-1624-4032-B42E-B92423D715DFQ34926806-CC5FBA55-C9E0-4FB5-A1C6-37A4FCDAFB77Q35671241-709ED088-62D9-4AEE-9321-CC989C133FD2Q36272032-AB784BAC-B792-4709-9687-F9C6660AFFBDQ36411919-F5981FD2-2D25-41CF-8790-006140C496F2Q36803506-96D9F27C-0D7A-427A-8CF7-A4B265C08089Q37163142-F7BE59D1-B33A-46A9-8DDD-8D98621727F3Q37594867-3D099AFC-3995-4199-9373-29365AB72E9CQ37616207-5ABD29FC-1B05-416E-9CE5-3B864FE59760Q37787307-5E8B4079-561E-4170-A637-A4BDF8F0FDC6Q37850886-A9EC7E58-F26F-42D2-B925-A0248C303DB6Q37854814-9B5755F5-D013-469C-9411-EB2D9FBDDEFEQ37955232-03C0B7DA-8CE7-4828-9FFD-6A9D76C89292Q37961823-7807155B-238D-416C-94B5-88EF17ADD2D0Q37998525-01433B0D-2514-4233-96E7-592416D52DFDQ38068294-DCD9B9D0-7711-454A-92A9-1126399586A5Q38082467-FD77EC88-7F6A-4FFA-AB46-B66DCAF1CF62Q38132927-2BAD2A8B-F9AD-4DE3-9C20-DCAB27EEA97BQ38253820-52E43E7D-36D0-4942-9FDB-32E95488015DQ38707185-B019EAF3-474C-4631-B86A-55A6C1A6CB48Q39483373-A2D2419E-0EDD-4A1C-833D-BF166B4A3C1FQ39703517-B6D56179-D2FF-44AA-AE02-FE39ABCD5914Q39785314-4933F489-0407-46CF-94B7-9DA13DF278BFQ39996605-9CEE5A1B-0AFC-4831-8BCC-1B047888A867Q40594420-6010963B-E1CE-4782-A850-62C0AE196DD6Q40619905-EA42E761-4BE1-4F41-B088-898AA6CA096D
P2860
Anticoagulation intensity and outcomes among patients prescribed oral anticoagulant therapy: a systematic review and meta-analysis.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
Anticoagulation intensity and ...... atic review and meta-analysis.
@ast
Anticoagulation intensity and ...... atic review and meta-analysis.
@en
type
label
Anticoagulation intensity and ...... atic review and meta-analysis.
@ast
Anticoagulation intensity and ...... atic review and meta-analysis.
@en
prefLabel
Anticoagulation intensity and ...... atic review and meta-analysis.
@ast
Anticoagulation intensity and ...... atic review and meta-analysis.
@en
P2093
P2860
P356
P1476
Anticoagulation intensity and ...... atic review and meta-analysis.
@en
P2093
Alan J Forster
Alison Jennings
Dean Fergusson
Natalie Oake
Steve Doucette
P2860
P304
P356
10.1503/CMAJ.080171
P407
P577
2008-07-01T00:00:00Z